BSESattva Sukun Lifecare Ltd· RetailingHighNeutral
Announced Thu, 4 Jun, 2026 · 20:33 IST

Audited Result

Revenue Growth 20pctPat NegativeNegative Operating CashflowResults View source PDFExplain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
+2.7%Reaction day
₹0.75
prior close
₹0.75
announcement price
After-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is used-0.0%+2.7% vs market
Retailing peers, median of 54sector · industry level+0.0%+2.7% vs sector

On the reaction day the stock moved 2.7 pts more than Nifty Microcap 250 and 2.7 pts more than its Retailing peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
+1.3
10m
+1.3
15m
+0.0
30m
+0.0
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
+2.7-0.0+2.7+0.0+2.7
Next day
+0.0-2.0+2.0-1.8+1.8
2d
+1.3-0.1+1.5-0.6+1.9
3d
+0.0-1.6+1.6-1.1+1.1
4d
+0.0-2.7+2.7-2.6+2.6
5d
+1.3+0.3+1.1-0.2+1.5
1w
+1.3+2.6-1.3+0.6+0.8
15d
+0.0+4.2-4.2-1.1+1.1
1m
+2.7+6.2-3.5+1.2+1.4
2m
-1.3+8.6-10.0-2.4+1.0
3m
+41.3+11.2+30.1-5.0+46.3
UpDownMarket · Nifty Microcap 250Sector · Retailing peers, median of 54Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

The company reported audited results for FY26, with consolidated net sales jumping sharply to Rs 3,224.86 lakhs from Rs 526.30 lakhs in FY25, driven by a Rs 19.16 crore rights issue completed in July 2025. However, profitability collapsed — consolidated PAT fell to Rs 21.17 lakhs from Rs 248.94 lakhs, while Q4 FY26 alone posted a loss of Rs 70.99 lakhs versus a profit of Rs 84.22 lakhs in Q4 FY25. Total expenses surged disproportionately, with purchase of stock-in-trade alone reaching Rs 3,377.29 lakhs versus Rs 367.62 lakhs in FY25. Operating cash flow turned deeply negative at Rs (1,434.02) lakhs on a consolidated basis. Auditor SSRV & Associates issued an unmodified opinion, and no deviation was reported in the use of rights issue proceeds.

Likely market impact

Shareholders should note a sharp divergence between strong top-line growth and weak bottom-line performance — the company scaled revenue but margins compressed significantly, and quarterly losses raise concerns about near-term profitability. Negative operating cash flow may pressure liquidity despite the recent rights issue funding.